Project: A novel synergetic approach for increased infection control and reduced device related complications

We will develop a new generation of central venous catheters (CVCs) that will prevent/ delay the development of catheter related blood stream infections (CRBSI) and prevent thrombus formation by providing a safe and effective medical device with in-built anti/non-thrombogenic properties. For the first time, a combination CVC will include a long lasting anti/non-thrombogenic coating with an active fixed biocompatible noble metal surface as a defence against infections and thrombosis formation.

Acronym	REDCATH (Reference Number: 9255)
Duration	01/11/2015 - 01/05/2018
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 2

Project partner

Number	Name	Role	Country
20070	Bactiguard AB	Coordinator	Sweden
20071	BioInteractions Ltd	Partner	United Kingdom